Exact Mass: 444.2888966
Exact Mass Matches: 444.2888966
Found 500 metabolites which its exact mass value is equals to given mass value 444.2888966
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
sn-3-O-(geranylgeranyl)glycerol 1-phosphate
C23H41O6P (444.26406160000005)
Menatetrenone
Menatetrenone, also known as MK-4, is a vitamin K compound used as a hemostatic agent, and also as adjunctive therapy for the pain of osteoporosis. Menatetrenone is one of the nine forms of vitamin K2 and is a short-chain menaquinone. MK-4 is produced via conversion of vitamin K1 in the body, in the testes, pancreas and arterial walls (Wikipedia). Vitamin K2 is found in brassicas. Vitamin K2 is widely distributed in green leaves and vegetables. It is a fat-soluble dietary factor effective in controlling blood coagulation. All members of the vitamin K group of vitamins share a methylated naphthoquinone ring structure and vary in the aliphatic side chain attached at the 3-position. Phylloquinone (also known as vitamin K1) invariably contains in its side chain four isoprenoid residues, one of which is unsaturated. Human milk contains between 1 and 4 micrograms/litre of vitamin K1, while formula-derived milk can contain up to 100 micrograms/litre in supplemented formulas. Vitamin K2 concentrations in human milk appear to be much lower than those of vitamin K1. It is estimated that there is a 0.25 to 1.7 percent occurrence of vitamin K deficiency bleeding in the first week of the infants life with a prevalence of 2-10 cases per 100,000 births. The biochemistry of how vitamin K is used to convert glutamic acid (Glu) to gamma-carboxyglutamic acid (Gla) has been elucidated over the past thirty years in academic laboratories throughout the world. Within the cell, vitamin K undergoes electron reduction to a reduced form of vitamin K (called vitamin K hydroquinone) by the enzyme vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes vitamin K hydroquinone to allow carboxylation of Glu to Gla; this enzyme is called the gamma-glutamyl carboxylase or the vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize vitamin K hydroquinone to vitamin K epoxide at the same time. The carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted into vitamin K by the vitamin K epoxide reductase. These two enzymes comprise the so-called vitamin K cycle. Vitamin K2 is one of the reasons why vitamin K is rarely deficient in a human diet (vitamin K is continually recycled in our cells). Vitamin K1 is also known as phylloquinone or phytomenadione (also called phytonadione). Vitamin K2 (menaquinone, menatetrenone) is normally produced by bacteria in the large intestine, and dietary deficiency is extremely rare unless the intestines are heavily damaged or are unable to absorb the molecule, or due to decreased production by normal flora, as seen in broad spectrum antibiotic use. Menaquinone-4 is a menaquinone whose side-chain contains 4 isoprene units in an all-trans-configuration. It has a role as a bone density conservation agent, a human metabolite, an antioxidant, an anti-inflammatory agent and a neuroprotective agent. Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma. Menatetrenone is a menaquinone compound and form of vitamin K2 with potential antineoplastic activity. Menatetrenone may act by modulating the signalling of certain tyrosine kinases, thereby affecting several transcription factors including c-myc and c-fos. This agent inhibits tumor cell growth by inducing apoptosis and cell cycle arrest. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization Inhibits bone resorption via PGE2 synthesis inhibition and other mechanisms. Antihaemorrhagic vitamin [CCD] A menaquinone whose side-chain contains 4 isoprene units in an all-trans-configuration. D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics Menaquinone-4 is a vitamin K, used as a hemostatic agent, and also a adjunctive therapy for the pain of osteoporosis.
1,25-Dihydroxyvitamin D3-26,23-lactone
1,25-Dihydroxyvitamin D3-26,23-lactone (1,25(OH)2D3-26,23-lactone) is a vitamin D3 metabolite. The formation of 1,25(OH)2D3-26,23-lactone occurs in normocalcemic states and in situations in which 1,25(OH)2D3 has been administered. (PMID: 6324253). 1,25-dihydroxyvitamin D3 and (23S)-1,23,25-trihydroxyvitamin D3 are efficient precursors to 1,25(OH)2D3-26,23-lactone. 1,25(OH)2D3-26,23-lactone has an inhibitory action of bone resorption and the lactone ring plays a major part in its expression. (PMID: 6548386, 1666030). 1,25-Dihydroxyvitamin D3-26,23-lactone (1,25(OH)2D3-26,23-lactone) is a vitamin D3 metabolite. The formation of 1,25(OH)2D3-26,23-lactone occurs in normocalcemic states and in situations in which 1,25(OH)2D3 has been administered. (PMID: 6324253) D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
Stearyl citrate
Stearyl citrate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")
2-Stearyl citrate
Antioxidant, sequestrant and emulsifier for use in margarine. Plasticiser for food contact packaging. Antioxidant, sequestrant and emulsifier for use in margarine. Plasticiser for food contact packaging
17-hydroxyprogesterone caproate
Calcitriol lactone
Proliferin
vitamin K2
[(3S,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] octadec-9-enoate
MG(6 keto-PGF1alpha/0:0/0:0)
MG(6 keto-PGF1alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(TXB2/0:0/0:0)
MG(TXB2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/6 keto-PGF1alpha/0:0)
MG(0:0/6 keto-PGF1alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/TXB2/0:0)
MG(0:0/TXB2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
12-epi-Scalarin
The 12-epimer of scalarin, a metabolite of marine sponges of the genus Spongia.
(19R)-9-acetyl-19-hydroxy-10,14-dimethyl-20-oxopentacyclo[11.8.0.0<2,10>.0<4,9 >.0<14,19>]henicos-17-yl acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.480 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.475 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.479 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.476
12-amino-6,9-di-sec-butyl-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione
12-O-acetyl-16-O-deacetyl-12,16-episcalarolbutenolide|12alpha-acetoxy-16beta-hydroxyscalarolbutenolide
3beta.27-Dihydroxy-25betaFH-cholesten-(5)-trion-(12.16.22)|3beta.27-dihydroxy-25betaFH-cholestene-(5)-trione-(12.16.22)
geranyl-1-O-alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranoside
12-deacetoxy-23-acetoxy-19-O-acetylscalarin|12-deacetoxy-23-acetoxyscalarin
(25R)-2alpha,3beta-Dihydroxy-5alpha-spirost-9(11)-en-12-on|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9(11)-en-12-one|(25R)-2alpha,3beta-dihydroxy-5alpha-spirost-9-en-12-one|9(11)-Dehydromanogenin|9-dehydromanogenin
(25S)-17alpha,25-dihydroxyspirost-4-en-3-one|diosbulbisin B
(6R*)-3,5-dihydroxy-4-<<(1S*,2R*,5R*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl>methyl>-6-methyl-2-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one|(6R*)-3,5-dihydroxy-4-{[(1S*,2R*,5R*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl]methyl}-6-methyl-2-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one
1-Acetoxy-3-methylene-6a,9,9,12a,14-pentamethyl-8-hydroxy-4,5-butano-2,3,4,5,6a,7,8,8a,9,10,11,12,12a,12b-tetradecahydro-1H-naphtho[2,1-b]oxocin-13-ene-15-one
12(R)-(beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside H
(22S,25S)-17alpha,26-dihydroxy-22,25-epoxyfurost-4-en-3-one|diosbulbisin C
(1S)-O4-(4-methyl-3-methylamino-beta-L-3-deoxy-arabinopyranosyl)-O6-(6-methyl-2-oxa-5-aza-bicyclo[2.2.2]oct-5-en-3-yl)-2-deoxy-streptamine|Gentamicin I-1
16-(2,5-dihydroxy-3-methylphenyl)-14-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10-trienoic acid
Dicadalenol|rel-1beta,7-Dihydroxy-2betaH-1,2,3,4-tetrahydro-14,8,2(O),7-dicadalenol
18R-acetoxy-20-hydroxy-2,10,19(21)-cladocoratrien-22(20)-olide|cladocoran A
Ala Asn Ile Lys
Scalarin
A scalarane sesterterpenoid lactone, a metabolite of marine sponges of the family Thorectidae (order dictyoceratida).
C27H40O5_(2alpha,3beta,5alpha,8xi,14xi,25S)-2,3-Dihydroxyspirost-9(11)-en-12-one
Ala Ala Lys Arg
Ala Ala Arg Lys
Ala Glu Ile Ile
Ala Glu Ile Leu
Ala Glu Leu Ile
Ala Glu Leu Leu
Ala Ile Glu Ile
Ala Ile Glu Leu
Ala Ile Ile Glu
Ala Ile Lys Asn
Ala Ile Leu Glu
Ala Ile Asn Lys
Ala Lys Ala Arg
Ala Lys Ile Asn
Ala Lys Lys Val
C20H40N6O5 (444.30600300000003)
Ala Lys Leu Asn
Ala Lys Asn Ile
Ala Lys Asn Leu
Ala Lys Gln Val
Ala Lys Arg Ala
Ala Lys Val Lys
C20H40N6O5 (444.30600300000003)
Ala Lys Val Gln
Ala Leu Glu Ile
Ala Leu Glu Leu
Ala Leu Ile Glu
Ala Leu Lys Asn
Ala Leu Leu Glu
Ala Leu Asn Lys
Ala Asn Lys Ile
Ala Asn Lys Leu
Ala Asn Leu Lys
Ala Gln Lys Val
Ala Gln Val Lys
Ala Arg Ala Lys
Ala Arg Lys Ala
Ala Val Lys Lys
C20H40N6O5 (444.30600300000003)
Ala Val Lys Gln
Ala Val Gln Lys
Asp Ile Val Val
Asp Leu Val Val
Asp Val Ile Val
Asp Val Leu Val
Asp Val Val Ile
Asp Val Val Leu
Glu Ala Ile Ile
Glu Ala Ile Leu
Glu Ala Leu Ile
Glu Ala Leu Leu
Glu Ile Ala Ile
Glu Ile Ala Leu
Glu Ile Ile Ala
Glu Ile Leu Ala
Glu Leu Ala Ile
Glu Leu Ala Leu
Glu Leu Ile Ala
Glu Leu Leu Ala
Glu Val Val Val
Gly Ile Lys Lys
C20H40N6O5 (444.30600300000003)
Gly Ile Lys Gln
Gly Ile Gln Lys
Gly Lys Ile Lys
C20H40N6O5 (444.30600300000003)
Gly Lys Ile Gln
Gly Lys Lys Ile
C20H40N6O5 (444.30600300000003)
Gly Lys Lys Leu
C20H40N6O5 (444.30600300000003)
Gly Lys Leu Lys
C20H40N6O5 (444.30600300000003)
Gly Lys Leu Gln
Gly Lys Gln Ile
Gly Lys Gln Leu
Gly Leu Lys Lys
C20H40N6O5 (444.30600300000003)
Gly Leu Lys Gln
Gly Leu Gln Lys
Gly Gln Ile Lys
Gly Gln Lys Ile
Gly Gln Lys Leu
Gly Gln Leu Lys
Ile Ala Glu Ile
Ile Ala Glu Leu
Ile Ala Ile Glu
Ile Ala Lys Asn
Ile Ala Leu Glu
Ile Ala Asn Lys
Ile Asp Val Val
Ile Glu Ala Ile
Ile Glu Ala Leu
Ile Glu Ile Ala
Ile Glu Leu Ala
Ile Gly Lys Lys
C20H40N6O5 (444.30600300000003)
Ile Gly Lys Gln
Ile Gly Gln Lys
Ile Ile Ala Glu
Ile Ile Glu Ala
Ile Ile Ile Ser
Ile Ile Leu Ser
Ile Ile Ser Ile
Ile Ile Ser Leu
Ile Ile Thr Val
Ile Ile Val Thr
Ile Lys Ala Asn
Ile Lys Gly Lys
C20H40N6O5 (444.30600300000003)
Ile Lys Gly Gln
Ile Lys Lys Gly
C20H40N6O5 (444.30600300000003)
Ile Lys Asn Ala
Ile Lys Gln Gly
Ile Leu Ala Glu
Ile Leu Glu Ala
Ile Leu Ile Ser
Ile Leu Leu Ser
Ile Leu Ser Ile
Ile Leu Ser Leu
Ile Leu Thr Val
Ile Leu Val Thr
Ile Asn Ala Lys
Ile Asn Lys Ala
Ile Gln Gly Lys
Ile Gln Lys Gly
Ile Ser Ile Ile
Ile Ser Ile Leu
Ile Ser Leu Ile
Ile Ser Leu Leu
Ile Thr Ile Val
Ile Thr Leu Val
Ile Thr Val Ile
Ile Thr Val Leu
Ile Val Asp Val
Ile Val Ile Thr
Ile Val Leu Thr
Ile Val Thr Ile
Ile Val Thr Leu
Ile Val Val Asp
Lys Ala Ala Arg
Lys Ala Ile Asn
Lys Ala Lys Val
C20H40N6O5 (444.30600300000003)
Lys Ala Leu Asn
Lys Ala Asn Ile
Lys Ala Asn Leu
Lys Ala Gln Val
Lys Ala Arg Ala
Lys Ala Val Lys
C20H40N6O5 (444.30600300000003)
Lys Ala Val Gln
Lys Gly Ile Lys
C20H40N6O5 (444.30600300000003)
Lys Gly Ile Gln
Lys Gly Lys Ile
C20H40N6O5 (444.30600300000003)
Lys Gly Lys Leu
C20H40N6O5 (444.30600300000003)
Lys Gly Leu Lys
C20H40N6O5 (444.30600300000003)
Lys Gly Leu Gln
Lys Gly Gln Ile
Lys Gly Gln Leu
Lys Ile Ala Asn
Lys Ile Gly Lys
C20H40N6O5 (444.30600300000003)
Lys Ile Gly Gln
Lys Ile Lys Gly
C20H40N6O5 (444.30600300000003)
Lys Ile Asn Ala
Lys Ile Gln Gly
Lys Lys Ala Val
C20H40N6O5 (444.30600300000003)
Lys Lys Gly Ile
C20H40N6O5 (444.30600300000003)
Lys Lys Gly Leu
C20H40N6O5 (444.30600300000003)
Lys Lys Ile Gly
C20H40N6O5 (444.30600300000003)
Lys Lys Leu Gly
C20H40N6O5 (444.30600300000003)
Lys Lys Val Ala
C20H40N6O5 (444.30600300000003)
Lys Leu Ala Asn
Lys Leu Gly Lys
C20H40N6O5 (444.30600300000003)
Lys Leu Gly Gln
Lys Leu Lys Gly
C20H40N6O5 (444.30600300000003)
Lys Leu Asn Ala
Lys Leu Gln Gly
Lys Asn Ala Ile
Lys Asn Ala Leu
Lys Asn Ile Ala
Lys Asn Leu Ala
Lys Gln Ala Val
Lys Gln Gly Ile
Lys Gln Gly Leu
Lys Gln Ile Gly
Lys Gln Leu Gly
Lys Gln Val Ala
Lys Arg Ala Ala
Lys Val Ala Lys
C20H40N6O5 (444.30600300000003)
Lys Val Ala Gln
Lys Val Lys Ala
C20H40N6O5 (444.30600300000003)
Lys Val Gln Ala
Leu Ala Glu Ile
Leu Ala Glu Leu
Leu Ala Ile Glu
Leu Ala Lys Asn
Leu Ala Leu Glu
Leu Ala Asn Lys
Leu Asp Val Val
Leu Glu Ala Ile
Leu Glu Ala Leu
Leu Glu Ile Ala
Leu Glu Leu Ala
Leu Gly Lys Lys
C20H40N6O5 (444.30600300000003)
Leu Gly Lys Gln
Leu Gly Gln Lys
Leu Ile Ala Glu
Leu Ile Glu Ala
Leu Ile Ile Ser
Leu Ile Leu Ser
Leu Ile Ser Ile
Leu Ile Ser Leu
Leu Ile Thr Val
Leu Ile Val Thr
Leu Lys Ala Asn
Leu Lys Gly Lys
C20H40N6O5 (444.30600300000003)
Leu Lys Gly Gln
Leu Lys Lys Gly
C20H40N6O5 (444.30600300000003)
Leu Lys Asn Ala
Leu Lys Gln Gly
Leu Leu Ala Glu
Leu Leu Glu Ala
Leu Leu Ile Ser
Leu Leu Leu Ser
Leu Leu Ser Ile
Leu Leu Ser Leu
Leu Leu Thr Val
Leu Leu Val Thr
Leu Asn Ala Lys
Leu Asn Lys Ala
Leu Gln Gly Lys
Leu Gln Lys Gly
Leu Ser Ile Ile
Leu Ser Ile Leu
Leu Ser Leu Ile
Leu Ser Leu Leu
Leu Thr Ile Val
Leu Thr Leu Val
Leu Thr Val Ile
Leu Thr Val Leu
Leu Val Asp Val
Leu Val Ile Thr
Leu Val Leu Thr
Leu Val Thr Ile
Leu Val Thr Leu
Leu Val Val Asp
Asn Ala Ile Lys
Asn Ala Lys Ile
Asn Ala Lys Leu
Asn Ala Leu Lys
Asn Ile Ala Lys
Asn Ile Lys Ala
Asn Lys Ala Ile
Asn Lys Ala Leu
Asn Lys Ile Ala
Asn Lys Leu Ala
Asn Leu Ala Lys
Asn Leu Lys Ala
Gln Ala Lys Val
Gln Ala Val Lys
Gln Gly Ile Lys
Gln Gly Lys Ile
Gln Gly Lys Leu
Gln Gly Leu Lys
Gln Ile Gly Lys
Gln Ile Lys Gly
Gln Lys Ala Val
Gln Lys Gly Ile
Gln Lys Gly Leu
Gln Lys Ile Gly
Gln Lys Leu Gly
Gln Lys Val Ala
Gln Leu Gly Lys
Gln Leu Lys Gly
Gln Val Ala Lys
Gln Val Lys Ala
Arg Ala Ala Lys
Arg Ala Lys Ala
Arg Lys Ala Ala
Ser Ile Ile Ile
Ser Ile Ile Leu
Ser Ile Leu Ile
Ser Ile Leu Leu
Ser Leu Ile Ile
Ser Leu Ile Leu
Ser Leu Leu Ile
Ser Leu Leu Leu
Thr Ile Ile Val
Thr Ile Leu Val
Thr Ile Val Ile
Thr Ile Val Leu
Thr Leu Ile Val
Thr Leu Leu Val
Thr Leu Val Ile
Thr Leu Val Leu
Thr Val Ile Ile
Thr Val Ile Leu
Thr Val Leu Ile
Thr Val Leu Leu
Val Ala Lys Lys
C20H40N6O5 (444.30600300000003)
Val Ala Lys Gln
Val Ala Gln Lys
Val Asp Ile Val
Val Asp Leu Val
Val Asp Val Ile
Val Asp Val Leu
Val Glu Val Val
Val Ile Asp Val
Val Ile Ile Thr
Val Ile Leu Thr
Val Ile Thr Ile
Val Ile Thr Leu
Val Ile Val Asp
Val Lys Ala Lys
C20H40N6O5 (444.30600300000003)
Val Lys Ala Gln
Val Lys Lys Ala
C20H40N6O5 (444.30600300000003)
Val Lys Gln Ala
Val Leu Asp Val
Val Leu Ile Thr
Val Leu Leu Thr
Val Leu Thr Ile
Val Leu Thr Leu
Val Leu Val Asp
Val Gln Ala Lys
Val Gln Lys Ala
Val Thr Ile Ile
Val Thr Ile Leu
Val Thr Leu Ile
Val Thr Leu Leu
Val Val Asp Ile
Val Val Asp Leu
Val Val Glu Val
Val Val Ile Asp
Val Val Leu Asp
(23S,25R)-25-hydroxyvitamin D3 26,23-peroxylactone / (23S,25R)-25-hydroxycholecalciferol 26,23-peroxylactone
(5Z,7E)-(1S,3R,23R,25R)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone
(5Z,7E)-(1S,3R,23S,25R)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone
(5Z,7E)-(1S,3R,23R,25S)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone
(5Z,7E)-(1S,3R,23S,25S)-1,3,25-trihydroxy-9,10-seco-5,7,10(19)-cholestatrieno-26,23-lactone
AL 8810 isopropyl ester
LPA O-20:4
C23H41O6P (444.26406160000005)
(23S,25R)-25-hydroxyvitamin D3 26,23-peroxylactone
(23R,25R)-1alpha,25-dihydroxyvitamin D3 26,23-lactone
(23S,25R)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23S,25R)-1alpha,25-dihydroxycholecalciferol 26,23-lactone
(23R,25S)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23R,25S)-1alpha,25-dihydroxycholecalciferol 26,23-lactone
(23S,25S)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23S,25S)-1alpha,25-dihydroxycholecalciferol 26,23-lactone
12-O-acetyl-16-O-deacetyl-16-epi-scalarobutenolide
A scalarane sesterterpenoid isolated from the marine sponge Hyrtios erectus that exhibits antineoplastic activity.
[4-[[4-(diethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]diethylammonium acetate
2-(1-(4-(2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)propan- 2-yl)phenethyl)piperidin-4-yl)-1H-benzo[d]imidazole
menaquinone
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics Menaquinone-4 is a vitamin K, used as a hemostatic agent, and also a adjunctive therapy for the pain of osteoporosis.
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyl-24-oxotetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenoic acid
(3R,5S)-5-[(2R)-2-[(1R,3AR,4E,7AR)-4-[(2Z)-2-[(3S,5S)-3,5-Dihydroxy-2-methylidene-cyclohexylidene]ethylidene]-7A-methyl-2,3,3A,5,6,7-hexahydro-1H-inden-1-YL]propyl]-3-hydroxy-3-methyl-oxolan-2-one
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
(17-acetyl-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-1-yl) hexanoate
[(3S,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl] octadec-9-enoate
2-[(3Z,7E,12Z)-11,17-dihydroxy-1,4,8,12-tetramethyl-18-oxo-16-bicyclo[13.3.0]octadeca-3,7,12,16-tetraenyl]propyl acetate
1-[(2,4-dimethoxyphenyl)methyl]-N-(2-phenylethyl)-N-(phenylmethyl)-4-piperidinamine
12-Deacetoxy-21-acetoxyscalarin
A scalarane sesterterpenoid isolated from the marine sponge Hyrtios erectus that exhibits antineoplastic activity.
3-O-(geranylgeranyl)glycerol 1-phosphate
C23H41O6P (444.26406160000005)
18-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctadecanoic acid
(17R)-17-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxooctadecanoic acid
1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
sn-1-O-(geranylgeranyl)glycerol 3-phosphate
C23H41O6P (444.26406160000005)
[3-carboxy-2-[(7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropyl]-trimethylazanium
C27H42NO4+ (444.31136720000006)
(1-acetyloxy-3-hydroxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
1,25-Dihydroxyvitamin D3-26,23-lactone
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols
(4s,5as,5br,7as,11as,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1-oxo-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-4-yl acetate
4',16'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-11'-one
(2r,3s,4s,4ar,17r,18ar)-17-hexyl-3,4-dihydroxy-2-(hydroxymethyl)-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-6-one
3,5-dihydroxy-4-{[2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-6-methyl-6-(3-methylbut-2-en-1-yl)-2-(3-methylbutanoyl)cyclohexa-2,4-dien-1-one
(3r,4s,5s,6r,7r,8r)-5,6,7-trihydroxy-2,2,4,6,8-pentamethyl-9-oxooxonan-3-yl (2e,4r)-4-hydroxydec-2-enoate
(2s)-2-[(3ar,13r,16as)-2,13-dihydroxy-3a,6,10,14-tetramethyl-3-oxo-4h,7h,8h,11h,12h,13h,16h,16ah-cyclopenta[15]annulen-1-yl]propyl acetate
4-hydroxy-3-{[2-(3-hydroxy-2-methylpropyl)-5a,9b-dimethyl-7-methylidene-octahydro-1h-naphtho[2,1-b]furan-6-yl]methyl}-5,6-dimethylpyran-2-one
8-(1-hydroxy-2,2,6-trimethylcyclohexyl)-6-methyl-2-[3-(5-oxo-2h-furan-3-yl)prop-2-en-1-ylidene]oct-5-en-1-yl acetate
4-hydroxy-3-{[3-(2-hydroxypropan-2-yl)-6a,10b-dimethyl-8-methylidene-decahydronaphtho[2,1-b]pyran-7-yl]methyl}-5,6-dimethylpyran-2-one
(3r,8as)-5-propyl-3-(tetradecyloxy)-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
(1s,2r,3r,4ar,5s,8as)-4a,5-dimethyl-2-{[(3e)-3-methylpent-3-enoyl]oxy}-7-oxo-3-(prop-1-en-2-yl)-octahydronaphthalen-1-yl (3e)-3-methylpent-3-enoate
(3r,8ar)-3-(hexadecyloxy)-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)
(5as,5br,7ar,9s,11ar,11br,13r,13as)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-1-oxo-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-9-yl acetate
(1'r,2r,2's,4's,5s,7's,8's,9's,12's,13'r)-5,8'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-17'-en-16'-one
3-(hexadecyloxy)-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O6P (444.26406160000005)